Research & Development
Pathology & AI
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Alverno Laboratories to expand Ibex’s AI-powered cancer diagnostics suite throughout its Midwest network
Alverno, among the first U.S. laboratory networks to digitize its pathology services, is also the first to offer the Ibex AI-supported cancer diagnostic service in the U.S.
March 9, 2023
Viz.ai platform to be used in patient enrollment for pulmonary embolism trial
Research institutions participating in the PE-TRACT trial will use the platform, Viz Recruit, to find, screen, and enroll trial candidates.
March 6, 2023
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
The integrated Lunit Scope PD-L1 algorithm will augment the TissueNext test’s detection of the PD-L1 biomarker in tissue samples using an AI-based scoring system.
February 1, 2023
With Bill & Melinda Gates Foundation grant, VisualDx to develop diagnostic, surveillance tools for underserved
The firm said it will use the funds to expand equitable access to its clinical decision support, artificial intelligence, and machine learning tools.
January 18, 2023
Paige joins forces with Microsoft on pathology AI
Digital pathology company Paige is partnering with Microsoft on AI technology to develop clinical applications and computational biomarkers for digital pathology images to transform cancer diagnosis and patient care.
January 12, 2023
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Avenda Health gets FDA 510(k) clearance for iQuest prostate cancer platform
The iQuest platform provides physicians with a 3D visualization, enabling treatment decisions that consider the extent of the cancer rather than treating the whole organ.
December 8, 2022
PathomIQ presents data on AI predictive model at SABCS
The model predicts the response to neoadjuvant chemotherapy in patients with triple-negative breast cancer through extracting morphological features.
December 8, 2022
Source LDPath, Ibex Medical Analytics ink agreement to deploy AI-enabled pathology platform
AI-enabled tools will be used to diagnose multiple tissue types and improve diagnostic accuracy and efficiency, Source LDPath said.
December 7, 2022
Klick Applied Sciences showcases study data demonstrating AI method for predicting diabetes
Scientists from Klick Applied Sciences are developing a method of predicting diabetes by combining continuous glucose monitor technology with machine-learning models.
December 2, 2022
PreciseDx, Dordrecht Albert Schweitzer Hospital to evaluate cancer risk stratification platform
The Laboratory of Pathology at Dordrecht, in the Netherlands, will study the performance of PreciseDx's artificial intelligence-based cancer risk stratification platform and test.
November 29, 2022
Deep Bio, Visiopharm collaborate on AI-based digital pathology for prostate cancer diagnosis
The collaboration brings Deep Prostate AI software to Visiopharm’s European diagnostic customers, allowing pathologists to obtain an analysis of whole-slide images of H&E-stained biopsy tissue specimens.
November 15, 2022
Page 1 of 13